DR. MARCO A COSTA, M.D.
Osteopathic Medicine at Euclid Ave, Cleveland, OH

License number
Ohio MFC1413
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
Ohio 81-000076
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
Ohio 81-000083
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
11100 Euclid Ave, Cleveland, OH 44106
Phone
(216) 844-3800
(216) 286-6295
(216) 286-6341 (Fax)

Personal information

See more information about MARCO A COSTA at radaris.com
Name
Address
Phone
Marco Da Costa
2539 Cedarwood Rd, Cleveland, OH 44124
(904) 273-9765

Organization information

See more information about MARCO A COSTA at bizstanding.com

University Hospitals - Marco Costa MD

11100 Euclid Ave, Cleveland, OH 44106

Categories:
Cardiology Physicians & Surgeons
Phone:
(216) 844-1000 (Phone)
Specialties:
Infectious Disease, Metabolic Problems, Pulmonary Diseases
Products:
Fitness Programs, Wellness
Payment options:
American Express, Discover Card, MasterCard, ...
Open Hours:
Hours by Appointment
Additional:
A Multi-Specialty Group Practice Affiliated With Case Western Reserve Medical School and University Hospitals of Cleveland, University Physicians Accepts All Major Health Plans and All of Our Physicia...

Professional information

Marco A Costa Photo 1

Dr. Marco A Costa, Cleveland OH - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
University Hospital Medical Grp Practice
11100 Euclid Ave SUITE 3001, Cleveland 44106
(216) 844-8500 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Impella Device, Peripheral Artery Catheterization, Thoracentesis
Conditions:
Aneurysm and Dissection of Heart, Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Autonomic Disorders, Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart and Chronic Kidney Disease, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Septal Defect, Tricuspid Valve Disease
Languages:
English
Hospitals:
University Hospital Medical Grp Practice
11100 Euclid Ave SUITE 3001, Cleveland 44106
University Hospitals Case Medical Center
11100 Euclid Ave, Cleveland 44106
University Hospitals Geauga Medical Center
13207 Ravenna Rd, Chardon 44024
Education:
Medical School
Universidade Federal De Minas Gerais, Faculdade De Medicina
Graduated: 1994


Marco Costa Photo 2

Professor Of Medicine; Director, Interventional Cardiovasc. Center; Director, Research And Innovation Center

Position:
Professor of Medicine at Case Western Reserve University, Director, Interventional Cardiovascular Center at University Hospitals of Cleveland, Director, Research and Innovation Center at University Hospitals of Cleveland, Director, Cardiovascular Imaging Core Laboratories at University Hospitals of Cleveland
Location:
Cleveland, Ohio
Industry:
Hospital & Health Care
Work:
Case Western Reserve University - Cleveland, Ohio since Oct 2007 - Professor of Medicine University Hospitals of Cleveland since Oct 2007 - Director, Interventional Cardiovascular Center University Hospitals of Cleveland since Oct 2007 - Director, Research and Innovation Center University Hospitals of Cleveland since Oct 2007 - Director, Cardiovascular Imaging Core Laboratories University of Florida - Jacksonville, FL Sep 2001 - Oct 2007 - Director, Cardiovascular Imaging Core Laboratories University of Florida Sep 2001 - Sep 2007 - Associate Professor of Medicine University of Florida - Jacksonville, FL Sep 2001 - Sep 2007 - Director, Research - Cardiovascular Division Instituto Dante Pazzanese de Cardiologia - Sao Paulo, Brazil Mar 2000 - Aug 2001 - Director, Interventional Cardiology Research
Education:
Erasmus University Rotterdam 1998 - 2000
Doctor of Philosophy (PhD), Medicine, Interventional Cardiology
Universidade Federal de Minas Gerais 1989 - 1994
Doctor of Medicine (MD), Medicine


Marco Costa Photo 3

Marco Costa, Cleveland OH

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
UH Case Medical Center
11100 Euclid Ave, Cleveland, OH 44106 Shands Jacksonville
655 W 8Th St, Jacksonville, FL 32209
Education:
Universidade Federal De Minas Gerais (1994)


Marco Costa Photo 4

Segmentation And Quantification For Intravascular Optical Coherence Tomography Images

US Patent:
2012007, Mar 29, 2012
Filed:
Aug 2, 2011
Appl. No.:
13/196845
Inventors:
Andrew Rollins - Highland Hts OH, US
David Wilson - Clev. Hts. OH, US
Marco Costa - Pepper Pike OH, US
Hiram Bezerra - Shaker Heights OH, US
Zhao Wang - Cleveland OH, US
Assignee:
CASE WESTERN RESERVE UNIVERSITY - Cleveland OH
International Classification:
G01B 9/02, G06K 9/00
US Classification:
356479, 382131
Abstract:
A system and related methods for automatic or semi-automatic segmentation and quantification of blood vessel structure and physiology, including segmentation and quantification of lumen, guide wire, vessel wall, calcified plaques, fibrous caps, macrophages, metallic and bioresorbable stents are described, and including visualization of results. Calcified plaque segmentation can be used to estimate the distribution of superficial calcification and inform strategies stenting. Volumetric segmentation and quantification of fibrous caps can provide more comprehensive information of the mechanisms behind plaque rupture. Quantification of macrophages can aid diagnosis and prediction of unstable plaque and associated acute coronary events. Automated detection and quantification of metallic and bioresorbable stents can greatly reduce the analysis time and facilitate timely decision making for intervention procedures.


Marco Costa Photo 5

Method For Amplification And Functional Enhancment Of Blood Derived Progenitor Cells Using A Closed Culture System

US Patent:
2012000, Jan 5, 2012
Filed:
Jun 20, 2011
Appl. No.:
13/164392
Inventors:
Marco A. Costa - Pepper Pike OH, US
Masakazu Ishikawa - Shaker Heights OH, US
Takayuki Asahara - Tokyo, JP
Haruchika Masuda - Kanagawa, JP
International Classification:
C12N 5/078, C12N 5/02
US Classification:
435372, 435325, 435406
Abstract:
The present invention provides a method for expanding and improving functional capacity of human adult-derived progenitor cells in vitro using a closed culture system. The present invention provides a favorable condition for cell therapy to promote tissue repair and organogenesis via vasculogenesis and angiogenesis in clinical settings. The proposed closed bag culture system for culturing hemangioblast comprises of, in one embodiment, a serum-free culture medium containing one or more factors selected from the group consisting of stem cell growth factor, interleukin-6, FMS-like tyrosine kinase 3, thrombopoietin, and vascular endothelial growth factor and a kit for the preparation of the serum-free culture medium and the like.


Marco Costa Photo 6

Non-Contact System And Method For Monitoring A Physiological Condition

US Patent:
2012010, Apr 26, 2012
Filed:
Oct 26, 2010
Appl. No.:
12/912286
Inventors:
CANDIDA DESJARDINS - Cleveland Heights OH, US
Marco Costa - Cleveland OH, US
Lynn Antonelli - Cranston RI, US
International Classification:
A61B 5/00
US Classification:
600300
Abstract:
Systems and methods are disclosed for measuring a physiological signal of a patient without having to contact the patient. A system can include a laser configured to provide an optical beam to a surface associated with a patient. A detector receives light from the surface in response to the optical beam. A controller is configured to generate velocity data representing a velocity of the surface based on the detected interference of the optical beam and the reflected light. A processor computes a corresponding displacement waveform representing displacement of the surface based on the velocity waveform, the displacement waveform representing the physiological condition.